BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 2932659)

  • 1. D2 dopamine receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in rat striatum.
    Battaglia G; Norman AB; Hess EJ; Creese I
    Neurosci Lett; 1985 Aug; 59(2):177-82. PubMed ID: 2932659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of dopamine receptors mediating inhibition of adenylate cyclase activity in rat striatum.
    Onali P; Olianas MC; Gessa GL
    Mol Pharmacol; 1985 Aug; 28(2):138-45. PubMed ID: 2410769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine receptor coupling to adenylyl cyclase in rat olfactory pathway: a combined pharmacological-radioautographic approach.
    Coronas V; Krantic S; Jourdan F; Moyse E
    Neuroscience; 1999 Apr; 90(1):69-78. PubMed ID: 10188934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Forskolin potentiates the stimulation of rat striatal adenylate cyclase mediated by D-1 dopamine receptors, guanine nucleotides, and sodium fluoride.
    Battaglia G; Norman AB; Hess EJ; Creese I
    J Neurochem; 1986 Apr; 46(4):1180-5. PubMed ID: 3005508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. D-2 dopamine receptor-mediated inhibition of pro-opiomelanocortin synthesis in rat intermediate lobe. Abolition by pertussis toxin or activators of adenylate cyclase.
    Cote TE; Felder R; Kebabian JW; Sekura RD; Reisine T; Affolter HU
    J Biol Chem; 1986 Apr; 261(10):4555-61. PubMed ID: 3957908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of adenylate cyclase inhibition in dopamine autoreceptor regulation of tyrosine hydroxylase in rat nucleus accumbens.
    Onali P; Olianas MC
    Neurosci Lett; 1989 Jul; 102(1):91-6. PubMed ID: 2571111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of a dopamine autoreceptor selective profile of B-HT 920 in functional in vitro model systems of D2 receptors in rat striatum.
    Drukarch B; Schepens E; Dolleman-Van der Weel MJ; De Boer P; Van Vliet BJ; Stoof JC
    Eur J Pharmacol; 1990 Oct; 187(2):257-69. PubMed ID: 1980248
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine enhances somatostatin receptor-mediated inhibition of adenylate cyclase in rat striatum and hippocampus.
    Rodríguez-Sánchez MN; Puebla L; López-Sañudo S; Rodríguez-Martín E; Martín-Espinosa A; Rodríguez-Pena MS; Juarranz MG; Arilla E
    J Neurosci Res; 1997 May; 48(3):238-48. PubMed ID: 9160246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopaminergic inhibition of catecholamine secretion from chromaffin cells: evidence that inhibition is mediated by D4 and D5 dopamine receptors.
    Dahmer MK; Senogles SE
    J Neurochem; 1996 Jan; 66(1):222-32. PubMed ID: 8522958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of vasoactive intestinal polypeptide (VIP) on forskolin stimulated adenylate cyclase in the caudate-putamen of the rat.
    Moser A; Drescher S
    Exp Brain Res; 1990; 79(2):383-7. PubMed ID: 2323384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological and biochemical characterization of dopamine receptors mediating stimulation of a high affinity GTPase in rat striatum.
    Onali P; Olianas MC
    Biochem Pharmacol; 1987 Sep; 36(17):2839-45. PubMed ID: 2820423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine D-1 receptor agonists combined with the selective D-2 agonist quinpirole facilitate the expression of oral stereotyped behaviour in rats.
    Arnt J; Hyttel J; Perregaard J
    Eur J Pharmacol; 1987 Jan; 133(2):137-45. PubMed ID: 2949991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute reserpine treatment induces down regulation of D-1 dopamine receptor associated adenylyl cyclase activity in rat striatum.
    Thomas KL; Rose S; Jenner P; Marsden CD
    Biochem Pharmacol; 1992 Jul; 44(1):83-91. PubMed ID: 1321631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of responsiveness at D2 dopamine receptors by receptor desensitization and adenylyl cyclase sensitization.
    Bates MD; Senogles SE; Bunzow JR; Liggett SB; Civelli O; Caron MG
    Mol Pharmacol; 1991 Jan; 39(1):55-63. PubMed ID: 1846220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine, acting through D-2 receptors, inhibits rat striatal adenylate cyclase by a GTP-dependent process.
    Cooper DM; Bier-Laning CM; Halford MK; Ahlijanian MK; Zahniser NR
    Mol Pharmacol; 1986 Feb; 29(2):113-9. PubMed ID: 3005824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensitization of endogenous and recombinant adenylate cyclase by activation of D2 dopamine receptors.
    Watts VJ; Neve KA
    Mol Pharmacol; 1996 Oct; 50(4):966-76. PubMed ID: 8863843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bidirectional regulation of cAMP generating system by dopamine-D1 and D2-receptors in the rat retina.
    Nowak JZ; Sek B; Schorderet M
    J Neural Transm Gen Sect; 1990; 81(3):235-40. PubMed ID: 1697754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissociation of the striatal D-2 dopamine receptor from adenylyl cyclase following 6-hydroxydopamine-induced denervation.
    Thomas KL; Rose S; Jenner P; Marsden CD
    Biochem Pharmacol; 1992 Jul; 44(1):73-82. PubMed ID: 1321630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinal dopamine D1 and D2 receptors: characterization by binding or pharmacological studies and physiological functions.
    Schorderet M; Nowak JZ
    Cell Mol Neurobiol; 1990 Sep; 10(3):303-25. PubMed ID: 2174740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions between opiate- and dopamine-induced effects on adenylate cyclase in rat striatum.
    O'Shaughnessy CT; Headley PM
    Eur J Pharmacol; 1986 Jun; 125(1):79-83. PubMed ID: 3015643
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.